Chemotherapy for Lung Cancer in HIV-positive Patients
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This is a phase II, multicenter, non-randomized, open-label study evaluating the combination
of pemetrexed plus carboplatin in HIV-positive patients with lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique